Elisabeth Kapaki
Department of Neurology
School of Medicine
Athens National University
Eginition Hospital
Greece
Name/email consistency: high
- Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration. Kapaki, E., Paraskevas, G.P., Papageorgiou, S.G., Bonakis, A., Kalfakis, N., Zalonis, I., Vassilopoulos, D. Alzheimer. Dis. Assoc. Disord (2008)
- Oxidative damage to plasma proteins in patients with chronic alcohol dependence: the effect of smoking. Kapaki, E., Liappas, I., Lyras, L., Paraskevas, G.P., Mamali, I., Theotoka, I., Bourboulis, N., Liosis, I., Petropoulou, O., Soldatos, K. In. Vivo (2007)
- Thyroid function in patients with Alzheimer disease: implications on response to anticholinesterase treatment. Kapaki, E., Paraskevas, G.P., Mantzou, E., Papapostolou, A., Alevizaki, M., Vassilopoulos, D. Alzheimer. Dis. Assoc. Disord (2006)
- The cognitive effects of cholinesterase inhibitor treatment in every-day practice. Kapaki, E., Paraskevas, G.P. Curr. Med. Res. Opin (2005)
- The diagnostic value of tau protein, beta-amyloid (1-42) and their ratio for the discrimination of alcohol-related cognitive disorders from Alzheimer's disease in the early stages. Kapaki, E., Liappas, I., Paraskevas, G.P., Theotoka, I., Rabavilas, A. Int. J. Geriatr. Psychiatry (2005)
- CSF tau protein and beta-amyloid (1-42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population. Kapaki, E., Paraskevas, G.P., Zalonis, I., Zournas, C. Eur. J. Neurol. (2003)
- Thyroid function in patients with Alzheimer's disease treated with cholinesterase inhibitors. Kapaki, E., Ilias, I., Paraskevas, G.P., Theotoka, I., Christakopoulou, I. Acta. Neurobiol. Exp. (Wars) (2003)